Assessment of Two Commercial Susceptibility Test Methods for Determination of Daptomycin MICs
- 1 June 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (6), 2126-2129
- https://doi.org/10.1128/jcm.00076-06
Abstract
Daptomycin is a lipopeptide antibiotic with activity against several important gram-positive bacterial pathogens, including drug-resistant staphylococci and enterococci. Because the mechanism of action of daptomycin is calcium-dependent depolarization of the cell membrane, susceptibility testing requires medium supplemented with a physiological level of calcium. This study assessed two Food and Drug Administration-cleared commercial test devices for determination of daptomycin MICs, Etest and JustOne. A collection of 220 selected isolates, including Staphylococcus aureus , coagulase-negative staphylococci, Enterococcus faecalis , E. faecium , E. avium , E. durans , E. casseliflavus , and E. gallinarum , were tested by both methods. Included in the collection were 22 S. aureus and 14 Enterococcus sp. isolates that were recovered from patients and were nonsusceptible on the basis of the daptomycin MICs. As the reference method for comparison, all isolates were tested by the Clinical and Laboratory Standards Institute broth microdilution method incorporating cation-adjusted Mueller-Hinton broth with 50 μg/ml calcium. Daptomycin MICs agreed, within 1 twofold dilution, for 97% of the isolates by Etest and for 100% by JustOne. However, daptomycin MICs determined by Etest were 1 dilution lower than the reference MICs for 65% of the Enterococcus sp. isolates tested. This resulted in 28.5% very major (VM) errors (4/14) with enterococci (all E. faecium ) but none (0/22) with staphylococci. Use of JustOne yielded MICs that were 1 dilution lower than the reference MICs for 69% of the staphylococci and 25% of the enterococci. This resulted in 13.6% VM errors (3/22) with staphylococci and 14.3% VM errors (2/14) with enterococci. The manufacturer-recommended JustOne inoculum preparation resulted in mean colony counts of only 5 × 10 4 to 1 × 10 5 CFU/ml in the wells of the strip. Increasing the inoculum to 3 × 10 5 to 4 × 10 5 CFU/ml eliminated two of five VM errors upon retesting. No major interpretive errors occurred with either device. In summary, daptomycin MICs generated by the Etest or JustOne method generally agreed within 1 dilution of the reference daptomycin MICs. However, both devices produced slightly lower MICs that resulted in some VM errors.Keywords
This publication has 14 references indexed in Scilit:
- Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin TherapyAntimicrobial Agents and Chemotherapy, 2005
- The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure InfectionsClinical Infectious Diseases, 2004
- Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agarJournal of Antimicrobial Chemotherapy, 2004
- In VitroActivity of Daptomycin against Vancomycin-Resistant Enterococci ofVarious Van Types and Comparison of Susceptibility TestingMethodsAntimicrobial Agents and Chemotherapy, 2003
- In VitroActivities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a Challenge Panel of Staphylococci and Enterococci, Including Vancomycin-IntermediateStaphylococcus aureusand Vancomycin-ResistantEnterococcus faeciumMicrobial Drug Resistance, 2003
- Resistance Studies with DaptomycinAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Daptomycin against 2,789 Clinical Isolates from 11 North American Medical CentersAntimicrobial Agents and Chemotherapy, 2001
- Bactericidal Activities of Two Daptomycin Regimens against Clinical Strains of Glycopeptide Intermediate-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococcus faecium , and Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Pharmacodynamic Model with Simulated Endocardial VegetationsAntimicrobial Agents and Chemotherapy, 2001
- Daptomycin disrupts membrane potential in growing Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1991
- Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranesBiochemistry, 1988